DrugCite
Search

NOZINAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Nozinan Adverse Events Reported to the FDA Over Time

How are Nozinan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Nozinan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Nozinan is flagged as the suspect drug causing the adverse event.

Most Common Nozinan Adverse Events Reported to the FDA

What are the most common Nozinan adverse events reported to the FDA?

Extrapyramidal Disorder
28 (1.77%)
Mesothelioma
26 (1.64%)
Somnolence
25 (1.58%)
Lung Neoplasm Malignant
21 (1.33%)
Agitation
18 (1.14%)
Pyrexia
18 (1.14%)
Insomnia
17 (1.07%)
Abdominal Pain
15 (.95%)
Blood Creatine Phosphokinase Increa...
15 (.95%)
Confusional State
15 (.95%)
Constipation
15 (.95%)
Show More Show More
Fall
15 (.95%)
Gait Disturbance
15 (.95%)
Cardio-respiratory Arrest
14 (.88%)
Drug Exposure During Pregnancy
14 (.88%)
Vomiting
14 (.88%)
Anxiety
13 (.82%)
Balance Disorder
13 (.82%)
Dysphagia
13 (.82%)
Hypotension
13 (.82%)
Multiple Drug Overdose Intentional
12 (.76%)
Self Injurious Behaviour
12 (.76%)
Coma
11 (.69%)
Intestinal Obstruction
11 (.69%)
Tachycardia
11 (.69%)
Weight Decreased
11 (.69%)
Drug Interaction
10 (.63%)
Dysarthria
10 (.63%)
Fatigue
10 (.63%)
Ileus Paralytic
10 (.63%)
Leukocytosis
10 (.63%)
Malaise
10 (.63%)
Neuroleptic Malignant Syndrome
10 (.63%)
Overdose
10 (.63%)
Rhabdomyolysis
10 (.63%)
Suicide Attempt
10 (.63%)
Decreased Appetite
9 (.57%)
Depression
9 (.57%)
Dizziness
9 (.57%)
Dyspnoea
9 (.57%)
Erectile Dysfunction
9 (.57%)
Hypothermia
9 (.57%)
Loss Of Consciousness
9 (.57%)
Sleep Disorder
9 (.57%)
Hyperthermia
8 (.51%)
Chest Pain
7 (.44%)
Death
7 (.44%)
Delirium
7 (.44%)
Dyskinesia
7 (.44%)
Headache
7 (.44%)
Inflammation
7 (.44%)
Neutropenia
7 (.44%)
Photosensitivity Reaction
7 (.44%)
Sinus Tachycardia
7 (.44%)
Sudden Death
7 (.44%)
Tinnitus
7 (.44%)
Altered State Of Consciousness
6 (.38%)
Back Pain
6 (.38%)
Cardiovascular Disorder
6 (.38%)
Chest Discomfort
6 (.38%)
Chronic Fatigue Syndrome
6 (.38%)
Completed Suicide
6 (.38%)
Depressed Level Of Consciousness
6 (.38%)
Disability
6 (.38%)
Drug Ineffective
6 (.38%)
Drug Level Increased
6 (.38%)
Drug Withdrawal Syndrome
6 (.38%)
Facial Palsy
6 (.38%)
Hallucination, Auditory
6 (.38%)
Heart Rate Decreased
6 (.38%)
Musculoskeletal Stiffness
6 (.38%)
Orthostatic Hypotension
6 (.38%)
Psychotic Disorder
6 (.38%)
Renal Failure Acute
6 (.38%)
Social Phobia
6 (.38%)
Somatisation Disorder
6 (.38%)
Syncope
6 (.38%)
Visual Acuity Reduced
6 (.38%)
Agranulocytosis
5 (.32%)
Asthenia
5 (.32%)
Condition Aggravated
5 (.32%)
Delusional Disorder, Persecutory Ty...
5 (.32%)
Disorientation
5 (.32%)
Electrocardiogram Qt Prolonged
5 (.32%)
Faecaloma
5 (.32%)
Haematuria
5 (.32%)
Hallucination
5 (.32%)
Hypersomnia
5 (.32%)
Hyponatraemia
5 (.32%)
Hypotonia
5 (.32%)
Multiple Drug Overdose
5 (.32%)
Myoglobin Blood Increased
5 (.32%)
Nervous System Disorder
5 (.32%)
Pancytopenia
5 (.32%)
Sexual Dysfunction
5 (.32%)
Shock
5 (.32%)
Thrombocytopenia
5 (.32%)
Toxic Epidermal Necrolysis
5 (.32%)
Transaminases Increased
5 (.32%)
Abortion Induced
4 (.25%)
Blood Creatinine Increased
4 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Nozinan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nozinan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Nozinan

What are the most common Nozinan adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Nozinan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Nozinan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Nozinan According to Those Reporting Adverse Events

Why are people taking Nozinan, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
101
Schizophrenia
31
Psychotic Disorder
29
Product Used For Unknown Indication
27
Anxiety
21
Depression
16
Show More Show More
Nausea
13
Relaxation Therapy
12
Ill-defined Disorder
11
Agitation
10
Sleep Disorder
8
Bipolar Disorder
7
Mania
7
Bipolar I Disorder
7
Delusional Disorder, Unspecified Ty...
5
Schizoaffective Disorder
5
Neuralgia
5
Self Injurious Behaviour
5
Psychomotor Hyperactivity
4
Abnormal Behaviour
3
Mental Disorder
3
Insomnia
3
Sedation
3
Depressive Symptom
3
Schizophrenia, Paranoid Type
2
Impulsive Behaviour
2
Impulse-control Disorder
2
Psychiatric Decompensation
2
Delirium
2
Childhood Psychosis
2
Intentional Overdose
2
Drug Exposure During Pregnancy
2
Major Depression
2
Irritability
2
Drug Tolerance
2
Foetal Exposure During Pregnancy
2
Antiemetic Supportive Care
2
Schizophrenia, Disorganised Type
2
Sedative Therapy
2
Schizophrenia, Residual Type
1
Post Procedural Pain
1
Unevaluable Event
1
Excitability
1
Maternal Drugs Affecting Foetus
1
Aggression
1
Conduct Disorder
1
Suicide Attempt
1
Drug Dependence
1
Alcoholism
1
Maternal Exposure Timing Unspecifie...
1
Acute Psychosis
1

Nozinan Case Reports

What Nozinan safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Nozinan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Nozinan.